The new 2017 European society of cardiology (ESC) guidelines: important changes for introduction into clinical practice
The paper gives an overview of the European Society of Cardiology (ESC) guidelines updated in 2017. The revised and amended guidelines for areas, such as dual antiplatelet therapy (DAT), treatment of patients with ST-segment elevation myocardial infarction (STEMI), and management of patients with va...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2017-12-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/viewFile/32283/pdf |
id |
doaj-f9a84b3802d44ce49b770ba61b8e2172 |
---|---|
record_format |
Article |
spelling |
doaj-f9a84b3802d44ce49b770ba61b8e21722020-11-25T03:32:38Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422017-12-0189124910.17116/terarkh201789124-929283The new 2017 European society of cardiology (ESC) guidelines: important changes for introduction into clinical practiceV V FominA A SvistunovD A NapalkovA A SokolovaA I SkripkaN A MorinaE A FedorovaThe paper gives an overview of the European Society of Cardiology (ESC) guidelines updated in 2017. The revised and amended guidelines for areas, such as dual antiplatelet therapy (DAT), treatment of patients with ST-segment elevation myocardial infarction (STEMI), and management of patients with valvular heart disease and peripheral artery disease, were presented in late summer of this year. The authors of this paper present an independent analysis and discussion of new data on the key issues of diagnosis and treatment in patients in the above areas. The recommendations on DAT pay special attention to the timing of the therapy and to the choice of its drugs. The updated data on the treatment of patients with STEMI accurately determine the time to percutaneous coronary interventions, approaches to revascularization; the updates touch upon fibrinolytic therapy and new approaches to lipid-lowering therapy too. Recommendations for the management of patients with peripheral artery atherosclerosis propose for the first time a section devoted to the choice of antiplatelet therapy (an antiaggregant and/or an anticoagulant) depending on the clinical situation.https://ter-arkhiv.ru/0040-3660/article/viewFile/32283/pdfantiplatelet therapyst-segment elevation myocardial infarctionvalvular heart diseasesperipheral artery diseases |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
V V Fomin A A Svistunov D A Napalkov A A Sokolova A I Skripka N A Morina E A Fedorova |
spellingShingle |
V V Fomin A A Svistunov D A Napalkov A A Sokolova A I Skripka N A Morina E A Fedorova The new 2017 European society of cardiology (ESC) guidelines: important changes for introduction into clinical practice Терапевтический архив antiplatelet therapy st-segment elevation myocardial infarction valvular heart diseases peripheral artery diseases |
author_facet |
V V Fomin A A Svistunov D A Napalkov A A Sokolova A I Skripka N A Morina E A Fedorova |
author_sort |
V V Fomin |
title |
The new 2017 European society of cardiology (ESC) guidelines: important changes for introduction into clinical practice |
title_short |
The new 2017 European society of cardiology (ESC) guidelines: important changes for introduction into clinical practice |
title_full |
The new 2017 European society of cardiology (ESC) guidelines: important changes for introduction into clinical practice |
title_fullStr |
The new 2017 European society of cardiology (ESC) guidelines: important changes for introduction into clinical practice |
title_full_unstemmed |
The new 2017 European society of cardiology (ESC) guidelines: important changes for introduction into clinical practice |
title_sort |
new 2017 european society of cardiology (esc) guidelines: important changes for introduction into clinical practice |
publisher |
"Consilium Medicum" Publishing house |
series |
Терапевтический архив |
issn |
0040-3660 2309-5342 |
publishDate |
2017-12-01 |
description |
The paper gives an overview of the European Society of Cardiology (ESC) guidelines updated in 2017. The revised and amended guidelines for areas, such as dual antiplatelet therapy (DAT), treatment of patients with ST-segment elevation myocardial infarction (STEMI), and management of patients with valvular heart disease and peripheral artery disease, were presented in late summer of this year. The authors of this paper present an independent analysis and discussion of new data on the key issues of diagnosis and treatment in patients in the above areas. The recommendations on DAT pay special attention to the timing of the therapy and to the choice of its drugs. The updated data on the treatment of patients with STEMI accurately determine the time to percutaneous coronary interventions, approaches to revascularization; the updates touch upon fibrinolytic therapy and new approaches to lipid-lowering therapy too. Recommendations for the management of patients with peripheral artery atherosclerosis propose for the first time a section devoted to the choice of antiplatelet therapy (an antiaggregant and/or an anticoagulant) depending on the clinical situation. |
topic |
antiplatelet therapy st-segment elevation myocardial infarction valvular heart diseases peripheral artery diseases |
url |
https://ter-arkhiv.ru/0040-3660/article/viewFile/32283/pdf |
work_keys_str_mv |
AT vvfomin thenew2017europeansocietyofcardiologyescguidelinesimportantchangesforintroductionintoclinicalpractice AT aasvistunov thenew2017europeansocietyofcardiologyescguidelinesimportantchangesforintroductionintoclinicalpractice AT danapalkov thenew2017europeansocietyofcardiologyescguidelinesimportantchangesforintroductionintoclinicalpractice AT aasokolova thenew2017europeansocietyofcardiologyescguidelinesimportantchangesforintroductionintoclinicalpractice AT aiskripka thenew2017europeansocietyofcardiologyescguidelinesimportantchangesforintroductionintoclinicalpractice AT namorina thenew2017europeansocietyofcardiologyescguidelinesimportantchangesforintroductionintoclinicalpractice AT eafedorova thenew2017europeansocietyofcardiologyescguidelinesimportantchangesforintroductionintoclinicalpractice AT vvfomin new2017europeansocietyofcardiologyescguidelinesimportantchangesforintroductionintoclinicalpractice AT aasvistunov new2017europeansocietyofcardiologyescguidelinesimportantchangesforintroductionintoclinicalpractice AT danapalkov new2017europeansocietyofcardiologyescguidelinesimportantchangesforintroductionintoclinicalpractice AT aasokolova new2017europeansocietyofcardiologyescguidelinesimportantchangesforintroductionintoclinicalpractice AT aiskripka new2017europeansocietyofcardiologyescguidelinesimportantchangesforintroductionintoclinicalpractice AT namorina new2017europeansocietyofcardiologyescguidelinesimportantchangesforintroductionintoclinicalpractice AT eafedorova new2017europeansocietyofcardiologyescguidelinesimportantchangesforintroductionintoclinicalpractice |
_version_ |
1724566955986255872 |